Join BOPA
Back to news articles

BOPA Survey – please complete

By Netty Cracknell on 26th October 2018

https://www.surveymonkey.co.uk/r/BOPA18

Dear Pharmacist or Pharmacy Technician,
 
The British Oncology Pharmacy Association (BOPA) are interested in the views of its past, present and future members.

 If you have, are or likely to be a member of BOPA we would be very grateful if you would complete this survey to inform us at our next Committee Meeting in Dec.  
 
https://www.surveymonkey.co.uk/r/BOPA18
 
 
The deadline for this survey is 18th November 2018.
 
Thank you in advance for your time.
 
Thank you for your time
Netty Cracknell
BOPA Secretary and Digital Lead
On behalf of The BOPA Committee
 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article